Publications by authors named "Harry Lau"

Claim this Profile
B
Bacteroides eggerthii: a new human gut probiotic against metabolic dysfunction-associated steatotic liver disease.
Harry Cheuk-Hay Lau, Jun Yu

Clin Mol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting cancer stem cells enhances multikinase inhibitor therapy in metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma.
Yasi Pan, Xiang Zhang, Chi Chun Wong, Huarong Chen, Stephanie Ma, Harry Cheuk Hay Lau

Gut· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nerve Injury Related to Firearm Extremity Trauma.
Emma Avery, Harry Lau, Stephanie Stefaniuk, Christine B Novak, Jana Dengler

Plast Surg (Oakv)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma.
Harry Cheuk-Hay Lau, Xiang Zhang, Jun Yu

Nat Rev Gastroenterol Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The gut microbiota in cancer immunity and immunotherapy.
Mingxu Xie, Xiang Li, Harry Cheuk-Hay Lau, Jun Yu

Cell Mol Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut microbiota in cancer initiation, development and therapy.
Ruyi Zhang, Xiang Zhang, Harry Cheuk Hay Lau, Jun Yu

Sci China Life Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diet, Gastric Microbiota, and Metabolites in Gastric Tumorigenesis.
Lanping Jiang, Harry Cheuk-Hay Lau, Ruijie Zeng, Jun Yu

Research (Wash D C)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-cohort analysis reveals colorectal cancer tumor location-associated fecal microbiota and their clinical impact.
Yufeng Lin, Harry Cheuk-Hay Lau, Chuanfa Liu, Xiao Ding, Yang Sun

Cell Host Microbe· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transmission of antimicrobial resistance genes from the environment to human gut is more pronounced in colorectal cancer patients than in healthy subjects.
Weixin Liu, Harry C H Lau, Xiao Ding, Xiaole Yin, William Ka Kei Wu

Imeta· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of gut microbiota on immune checkpoint inhibitors in multi-cancer and as microbial biomarkers for predicting therapeutic response.
Yufeng Lin, Mingxu Xie, Harry Cheuk-Hay Lau, Ruijie Zeng, Ruyi Zhang

Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic TM6SF2 activates antitumour immunity to suppress metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma and boosts immunotherapy.
Yating Zhang, Mingxu Xie, Jun Wen, Cong Liang, Qian Song, Harry Cheuk Hay Lau

Gut· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer.
Xueliang Wang, Yi Fang, Wei Liang, Chi Chun Wong, Huanlong Qin, Harry Cheuk-Hay Lau

Cancer Cell· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological treatment for metabolic dysfunction-associated steatotic liver disease and related disorders: Current and emerging therapeutic options.
Xiang Zhang, Harry Cheuk-Hay Lau, Jun Yu

Pharmacol Rev· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A blood-based biomarker panel for non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis.
Xiang Zhang, Ming-Hua Zheng, Dehua Liu, Yufeng Lin, Sherlot Juan Song, Harry Cheuk-Hay Lau

Cell Metab· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut-liver translocation of pathogen Klebsiella pneumoniae promotes hepatocellular carcinoma in mice.
Xueliang Wang, Yi Fang, Wei Liang, Yuhong Cai, Chi Chun Wong, Harry Cheuk-Hay Lau

Nat Microbiol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut-liver axis.
Xiang Zhang, Harry Cheuk-Hay Lau, Suki Ha, Chuanfa Liu, Cong Liang

Nat Metab· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut-liver axis.
Xiang Zhang, Harry Cheuk-Hay Lau, Suki Ha, Chuanfa Liu, Cong Liang

Nat Metab· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stomach microbiota in gastric cancer development and clinical implications.
Ruijie Zeng, Hongyan Gou, Harry Cheuk Hay Lau, Jun Yu

Gut· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut microbial metabolites: Shaping future diagnosis and treatment against gastrointestinal cancer.
Hongyan Gou, Ruijie Zeng, Harry Cheuk Hay Lau, Jun Yu

Pharmacol Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer.
Xueliang Wang, Yi Fang, Wei Liang, Chi Chun Wong, Huanlong Qin, Harry Cheuk-Hay Lau

Cancer Cell· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RUVBL1/2 Blockade Targets YTHDF1 Activity to Suppress m6A-Dependent Oncogenic Translation and Colorectal Tumorigenesis.
Danyu Chen, Fenfen Ji, Qiming Zhou, Henley Cheung, Yasi Pan, Harry C-H Lau

Cancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Appendix removal affects the subsequent cancer risk in Asian adults: A territory-wide population-based cohort study.
Chenhao Hu, Cosmos Liutao Guo, Harry Cheuk-Hay Lau, Feiyu Shi, Zhe Zhang, Louis Ho-Shing Lau

Cancer Lett· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkers.
Yang Sun, Xiang Zhang, Dong Hang, Harry Cheuk-Hay Lau, Jie Du

Cancer Cell· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer.
Yi Zhao, Shangru Li, Lefan Zhu, Mingle Huang, Yubin Xie, Harry Cheuk-Hay Lau

Cell Rep Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptostreptococcus anaerobius mediates anti-PD1 therapy resistance and exacerbates colorectal cancer via myeloid-derived suppressor cells in mice.
Yali Liu, Chi Chun Wong, Yanqiang Ding, Mengxue Gao, Jun Wen, Harry Cheuk-Hay Lau

Nat Microbiol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis